白云山 公告,其附属企业广州广药二期基金股权投资合伙企业(有限合伙)已完成收购 南京医药 集团股份有限公司11.04%股份的过户登记手续,涉及14455.743万股无限售流通股。本次交易于2026年2月26日完成过户登记,广药二期基金承诺自过户登记之日起18个月内不对外转让目标股份。
Source Link白云山 公告,其附属企业广州广药二期基金股权投资合伙企业(有限合伙)已完成收购 南京医药 集团股份有限公司11.04%股份的过户登记手续,涉及14455.743万股无限售流通股。本次交易于2026年2月26日完成过户登记,广药二期基金承诺自过户登记之日起18个月内不对外转让目标股份。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.